Accès ouvert

Pegylated liposomal doxorubicin for the treatment of Kaposi’s sarcoma in Maputo, Mozambique: first results of a prospective study

Article scientifique 2017 Autre

Résumé

This abstract corresponds with the following slides: https://f1000research.com/slides/6-721, presented at Médecins Sans Frontières UK Scientific Days: Medical Research 2017. To watch the presentation click here: https://f1000research.com/videos/6-848. This abstract is part of an F1000Research gateway that includes posters, slides and videos from the MSF Scientific Day: Medical Research 2017. To see more please visit: https://f1000research.com/gateways/MSF/scidays

Citer ce document

Coldiron, M., Zamudio, A., Sebastiani, T., Cossa, L., Ciglenečki, I., Rusch, B., Trellu, L., Molfino, L. (2017). Pegylated liposomal doxorubicin for the treatment of Kaposi’s sarcoma in Maputo, Mozambique: first results of a prospective study. https://doi.org/10.7490/f1000research.1114243.1

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Matthew E. Coldiron Ana Gabriela Gutierrez Zamudio Teresa Sebastiani Loide Cossa Iza Ciglenečki Barbara Rusch Laurence Toutous Trellu Lucas Molfino

Statistiques

Consultations : 2

Téléchargements : 0